/
June 1995 Canavan Disease Spongy Cerebral June 1995 Canavan Disease Spongy Cerebral

June 1995 Canavan Disease Spongy Cerebral - PDF document

sophia
sophia . @sophia
Follow
343 views
Uploaded On 2022-08-22

June 1995 Canavan Disease Spongy Cerebral - PPT Presentation

Tllcl Seoul Journml of Medicine Vol 36 No 28591 egeneration A Case Report Mee Hye Oh1 Chong Jai Kim1 Je G Hwangs Chang Wang4 Cho4 Dcpmrtrrzunts f Puthologv Rudil ID: 939641

naa spongy matalon degeneration spongy naa degeneration matalon aspartate dis fig brain acetyl matter canavan seoul myelin acid aspartoacylase

Share:

Link:

Embed:

Download Presentation from below link

Download Pdf The PPT/PDF document "June 1995 Canavan Disease Spongy Cerebra..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Tllcl Seoul Journml of Medicine Vol. 36, No. 2:85-91, June 1995 Canavan Disease (Spongy Cerebral ~egeneration) - A Case Report - Mee Hye Oh1, Chong Jai Kim1, Je G. Hwangs, Chang Wang4, Cho4 Dc~pmrtrrzunts ~f Puthologv , Rudi~log))~, Seoul National Universitjt Medicine, Seoul, of Alzheimer type I1 astrocytes throughout the cer- there was astrocytes and between myelin lamellae. Key words : Canuvan disease, Spongy cereb

ral degeneration, N-acetylaspartic acid, Aspartoacylase INTRODUCTION Canavan degener- at~on of wh~te matter, and is particularly preva- lent in Jewish people of Ashkenazi origin. The flrst patlent with leukodystrophy and N-acetylas- partic (NAA) to aspartoacylase with that choline in ~nvolved (Fig. 1). The involved wh~te matter did matter(Fig. 2A). contrast infusion. equal peak of NAA spectroscopy showed NAA(N-acetylaspartate)

com- Fig. 2. Proton MR spectroscopy showing relatively h~gh peak of the NAA comparing w~th that of cholrne rn left deep whrte matter (Frg 2A), Left basal ganglra reglon equal peak chol~ne (Fig 2B) vacuoles form from splitting myelin sheaths and intramyel~n~c flu~d accumulation sease remains obscure. Matalon et a/., ered increased excretion of D'Adamo et a/., & Shigematsu et a/., stressed the important role of N

AA in myelination. Brain is the only organ where biosynthesis of NAA been demonstrat- myelin, and formation CoA and aspartate by L -aspartate-N-acetyl transferase (Patel et a/., 1980). It is metabolized to aspartate and acetyl by aspar- toacylase, and aspartate is transformed into acetyl CoA by brain acetate t hiokinase. Acetyl CoA NAA level skin fibroblasts CD. prenatal diagnosis possible as a affected families (Matalon et

a/., the central nervous (van Bogaert Hum Pathol ; 4: 331 -346 Banker BQ, Victor H. Spongy degeneration of infancy. In Goodman R, Jews. New ; Banker BQ, Spongy de- the central 981 -1 L, Bertrand idiotie fam- iliale avec degerescence sponglieuse de neur- axe(note preliminaire). Acta Neurol Belg 1949; 49 : Spongy Degeneration Brain in North Hol- 3-1 32 Spongy degeneration system:a 4 cases literature. Neurology ; 15: 207-222 Canavan

MM. Schilder's encephalitis periaxialis d~ffusa. Arch Neurol ; 25: 299 -308 D'Adamo AF, Gidez LI, port mechanisms. -aspartic acid In de novo : Gambetti P, spongy degeneration disease). Acta ; 103-1 15 Globus Progressive degenerative encephalopathy(Sc Neurol Paychiatr ; 90-1 228 I, Venizelos partic due to aspartoacylase de- Metab Dis 1987; 10: 135 -1 41 Matalon R, K, Sebasta ~spartoacylase aciduria in ients with ; 29

: 463-471 Matalon R, Kaul RK, Casanova J et a/., Aspar- in Can- Metab Dis 1989; 12: 329-331 Matalon R, Kaul RK, Michals K. Canavan Dis- ease: Biochemical and Molecular Studies. J lnher Metab Dis 1993; 16: 744-752 Patel JB. Synthesis -aspartate by rat brain mitochondria and its involvement in mitochondria1 cytosolic carbon transport. Biochem J 1979 ; Okamura N, heat stable the conversion glutamic acid J Neurochem ; 40 : 81